key: cord-0788760-uwod0jd4 authors: Abdolahi, Shahrokh; Hosseini, Maryam; Rezaei, Ramazan; Mohebbi, Seyed Reza; Rostami-Nejad, Mohammad; Mojarad, Ehsan Nazemalhosseini; Mirjalali, Hamed; Yadegar, Abbas; Assadzadeh-Aghdaei, Hamid; Zali, Mohamad Reza; Baghaei, Kaveh title: Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjects date: 2022-01-05 journal: Infect Genet Evol DOI: 10.1016/j.meegid.2022.105207 sha: 427807f7aa9eeb9e3ae07dd8224f0b6d88a52f5b doc_id: 788760 cord_uid: uwod0jd4 Angiotensin-converting enzyme 2 (ACE2) acts as a key receptor for the spike of SARS-CoV-2. Two main microRNAs (miRs), miR-200c-3p and miR-421-5p, are considered to modulate the expression of ACE2 gene and alterations in the expression of these miRNAs may influence the outcomes of COVID-19 infection. Accordingly, we examined whether miRNAs directing ACE2 expression altered in the SARS-CoV-2 infection. 30 patients with COVID-19 included in the study. At the time of admission and discharge, the expression of miR-200c-3p and miR-421-5p, inflammatory cytokine IL-6, and regulatory T cells' expression profiles (CD4, CD25, and Foxp3) were examined using quantitative real-time PCR method. At the time of admission, the expression levels of miR-200c-3p and miR-421-5p as well as CD4, CD25, and Foxp3 significantly decreased while IL-6 expression notably enhanced. However, by the time of discharge, the expression levels of the genes were opposite to the time of admission. Moreover, Pearson correlation analysis indicated that IL-6 expression negatively correlated with Foxp3 and miR-200c-3p expressions despite miR-421-5p and miR-200c-3p positively correlated at admission time. By manipulating miR-200c-3p and miR-421-5p expressions and controlling the ACE2 level, it is plausible to modulate the inflammation by reducing IL-6 and maintenance tolerance hemostasis during COVID-19 infection. The novel coronavirus disease 2019 (COVID -19) has been dramatically affected 220 countries in the world [1] . Vigorous efforts to control the outbreak of COVID- 19 have not been practical yet, and prognostic factors which can support therapeutic approaches are still elusive. Similar to previous coronaviruses, SARS-CoV and the Middle East respiratory syndrome (MERS), the novel coronavirus named SARS-CoV-2, manifests severe symptoms such as acute respiratory distress syndrome (ARDS) and multiple organ failure in almost 20% infected patients [2, 3] . Notably, angiotensin-converting enzyme 2 (ACE2) has been identified as a substantial entry receptor for the spike protein of SARS-CoV-2, which is downregulated [4] during the COVID-19 infection [5] . ACE2 acts to maintain the balance of blood pressure and electrolyte in human bodies by playing a role in the renin-angiotensin-aldosterone system (RAAS) and reducing the angiotensin II levels in the circulation [6, 7] . It has been reported that higher ACE2 concentrations lead to increased vulnerability to SARS-CoV-2 infection [4] as a predominant expression of ACE2 occurs in the epithelial cells of the lung and intestine. These two organs act as the primary entry site for the SARS-CoV-2 [4] . Therefore, the extent of COVID-19 infection gets more prominent by ACE2 in patients with severe COVID-19. Several studies have reported that microRNAs (miRNAs) could modulate ACE2 expression in various cell types and diseases [8] . miRNAs are highly conserved small noncoding RNAs that can negatively regulate gene expressions. Growing evidence showed that serum miRNAs could serve as a novel prognostic marker for SARS-CoV-2 infection [9] . Among various miRNAs subjected to ACE2 regulator [10] , the miR-200 family, especially hsa-miR-200c-3p directly targets 3' UTR of ACE2 mRNA leading to decreased ACE2 expression. Expression of miR-200c-3p is induced through the NF-κB pathway during infection with the pandemic flu strain H5N1 and is associated with acute respiratory distress syndrome. In particular, the NF-κB signaling pathway is hyper-activated in SARS-CoV infections, suggesting that miR-200c-3p could also be up-regulated in patients with COVID-19, which subsequently result in decreased levels of ACE2 protein [11] . Additionally, ACE2 is subjected to posttranscriptional regulation by miR-421-5p which is implicated in the development of thrombosis [12] . miR-421-5p can also target hypoxia-responsive repressors (HRR) to disturb a balance J o u r n a l P r e -p r o o f Journal Pre-proof between inflammatory and anti-inflammatory processes and maintain constant overexpression of HIF-mediated inflammatory genes, leading to inflammation-induced lung damage [13] . IL-6 is a potent pro-inflammatory cytokine playing a substantial role in inflammatory responses, cancers, and viral infections [14, 15] . IL-6 is well-recognized in the development of COVID-19, which further affects clinical manifestations of the disease by enhancement of T helper 17 (Th17) differentiation and inhibition of regulatory T (Treg) cells [16, 17] . Regulatory T cells (Tregs) are a subpopulation of T cells that suppress the immune response, thereby preserving self-tolerance and homeostasis. Studies have shown that Tregs are able to repress cell proliferation and cytokine secretion and play a crucial role in preventing autoimmunity [18] . Tregs expressing CD4, FOXP3, and CD25 are thought to be derived from the naïve CD4+ cells [19] . Effector T cells also express CD4 and CD25, which are difficult to distinguish from each other [20] . Tregs secret A collection of inhibitory cytokines. Including TGFbeta, [21] and IL-10, [22] . It has also been demonstrated that Tregs can stimulate other cell types to express IL-10 [23] . On the contrary, Th17, CD4+ CD25+ Foxp3+ Treg cell accounts for modulation of the inflammation by producing the anti-inflammatory factors and suppressing both innate and adaptive immune responses. Treg cells take part in maintaining immune tolerance and balance between inflammatory and regulatory responses. The dysfunction of Treg cells is one of the causative mechanisms of the immune system dysregulation and hyper inflammation in COVID-19 [24, 25] . Regarding previous studies, high expression of ACE2 was associated with innate and adaptive immune response and enhanced inflammatory response induced by cytokine secretions such as IL-1, IL-8, and IL-6 [26] . Thus, we speculated that ACE2 directing miRNAs might be affected by inflammation and tolerance changes during COVID-19 disease. To this aim, we investigated the expression of two main ACE2 directing miRNAs, miR-200c-3p and miR-421-5p, in peripheral bloods of COVID-19 patients at admission and discharge time. In addition, we evaluated the correlation between ACE2 regulator miRNAs and immune response related factors in SARS-COV2 infection. According to the manufacturer's instructions, peripheral blood samples of patients and healthy volunteers were collected and total RNA isolated using a total RNA isolation kit (Yekta Tajhiz Azama, Tehran, Iran). To analyze mature miRNA, cDNA was generated by stem-loop R.T. primer, and subsequently, quantitative real-time PCR applying SYBR Green Master Mix (Ampliqon, Herlev, Denmark) was conducted. For mRNA analyses, cDNA was synthesized from 2 μg total RNA per sample using a cDNA synthesis kit (Yekta Tajhiz, Tehran, Iran). The quantitative real-time PCR (qPCR) assays were performed using the Rotor-Gene Q system (Qiagen, Hilden, Germany) and the Fast SYBR Green Master Mix (Ampliqon). GAPDH and U6 genes were used as endogenous controls for the normalization of mRNA and miRNA gene expressions. Relative quantification was calculated by the 2 (−ΔΔCt) method and expressed as relative to endogenous controls. The sequences of oligonucleotides used as qPCR primers were designed using the OLIGO v.7.56 software (Molecular Biology Insights, Inc, USA) and listed in Table 1 . Serum concentrations of IL-6 were determined by ELISA, we used a Human IL-6 kit from Karmania Pars Gene (Cat. No. KPG-HIL6). Inter-group comparisons were made by student t-test parametric analysis. All data were reported as mean±SD and p<0.05 was considered as statistically significant. Statistical analyses were The Pearson's correlation coefficient was applied to assess the linear relationship between continuous variables. In this study, 30 patients with COVID-19 confirmed by PCR and C.T. scan were admitted to the infectious ward of Taleghani Hospital, Shahid Beheshti University of Medical Sciences. 18 healthy control participants were recruited. The mean ages of patients were 59.67, and 68% and 32% were male and female, respectively. The mean ages of control were 32.7, and 42% and 58% were male and female, respectively. All healthy controls have been confirmed with no infection with pathogenic microorganisms or respiratory viruses other than SARS-CoV-2. All participants were included in the study only with written consent. ( Figure 1A , B). were significantly up-regulated compared to those at the time of discharge (0.58±0.14, 1.72±0.68, 0.64±0.18 respectively) (p<0.001). healthy control group (Figure 2 ). IL-6 protein level was evaluated as one of the critical regulators of severe COVID-19 patients. The mean concentration of IL-6 in the peripheral blood of SARS-COV-2 infected patients was 197 pg/ml, which 32-fold were higher than the healthy control group (P<0.0001) ( Figure 3 ). Pearson correlation analysis was performed to evaluate Foxp3, IL-6, miR-200c-3p, and miR-421 associations in peripheral blood samples of SARS-COV-2 patients. As shown in figure 4 , the relative expression of Foxp3, a key marker for Treg cells [27] , was negatively correlated with that of IL-6 in patients with COVID-19 (r=−0.55, P=0.03, Figure 4A ), although the correlation of miRNAs express ubiquitously across species and play significant roles in the development and perform diverse regulatory functions in cells, including viral infections [28, 29] . In many cases, miRNAs have been proposed as minimally invasive markers for the early detection of diseases, and human encoded miRNAs could be the finest candidates for the development of miRNAbased therapeutics in the management of SARS-CoV-2 infection [30] . In this study, we purposed [34, 35] . Considering miRNAs are the earliest molecular regulators, circulating such miRNAs could be a potential biomarker in the early identification of those at the risk of severe COVID-19 [31] . According to studies, the infection of cells by SARS viruses that bind ACE2 results in inhibition of ACE2 activity and decreased ACE2 expression in infected cells [36] [37] [38] [39] . Lung samples from patients with idiopathic pulmonary fibrosis (IPF) have decreased ACE2 expression associated with lung injury and fibrosis [40] . [47, 48] .Furthermore, studies showed high expression of ACE2 in young or older people, which along with IL-6 is effective in causing cytokine storms [47, 48] . According to our results and other studies, the low level of miR-200c did not inhibit the expression of ACE2, which in COVID-19 patients is associated with severity of the disease. In addition, we showed that mir-421, which is a negative regulator of ACE2, was reduced, which is in line with other findings regarding cytokine storm and Tregs inhibition, which is in contrast to the results of Ruan Pimenta et al. Therefore, studies are needed to elucidate exact molecular mechanisms. Cytokine storm is mainly observed in COVID-19 patients, and the crucial cytokine playing a role, in this case, is IL-6 [49] . IL-6 is a pleiotropic cytokine that could be induced due to the deregulated expression of ACE2 in COVID-19 patients. The changes in ACE2 expression lead to immune system dysfunction and cause cytokine release syndrome (CRS) [45] . This study showed that IL-6 in protein and mRNA levels increased significantly in COVID-19 infected patients ( Figure 3 ). Similar to our findings, L. Bergantini et al. And Jing Liu et al. showed upregulation of IL-6 levels compared to mild cases in a separate study. This increase has caused J o u r n a l P r e -p r o o f lymphopenia and a pro-inflammatory cytokine storm in severe COVID-19 patients compared to mild cases [50, 51] . The evaluation of the RNAseq data of SARS-COV2-infected and uninfected cell lines has shown that the expression of IL-6 significantly increased in infected cell lines [52] . Moreover, it has been elucidated that patients with high ACE2 expression are more likely to develop cytokine storms dominated by IL-6 [52] . In this regard, correlation analysis demonstrated a significantly negative association between the expression of IL-6 and miR-200c-3p, so that patients with the highest levels of IL-6 had the lowest expression of miR-200-3p. These results suggest that decreased miR-200c-3p expression in SARS-COV2 infection removes its inhibitory effects on ACE2, subsequently promoting cytokine storms by inducing the expression of IL-6. Infection of human epithelial cells by SARS-COV2 induces high levels of IL-6 compared to parainfluenza 2 virus and influenza A virus [53] . As reported by Xu et al., a dramatic increase in IL-6 could justify the presence of T helper 17 (Th17) in COVID-19 patients due to an essential role of IL-6 in the differentiation of Th17 cells as interacting with dendritic cells [54] . Correspondingly, IL-6 is a vital agent participating in regulating inflammatory Th17 cells/regulatory T (Treg) cells balance. Elevated circulating IL-6 levels contribute to the deregulation of the Treg/Th17 cell ratio toward an increase in Th17 cells, leading to high production of inflammatory cytokines by Th17 cell activation. Accumulating body of data revealed that severe COVID-19 patients had a notable decline in Treg cell levels [24, 55] meanwhile increased levels of Th17 cells culminating in diminished the Treg/Th17 cell ratio [54, 56] . CD4+ CD25+ Foxp3+ Treg cells are critical modulators of the inflammation by producing the anti-inflammatory factors maintaining immune tolerance and balance between inflammatory and regulatory responses [24, 25] . Consistently, we showed the adverse correlation between IL-6 and FOXp3 expressions, indicating the opposite relationship between inflammation/tolerance in our study subjects. Furthermore, we demonstrated significant alteration in CD25 marker in admission and discharge patients which hypothesized these changes in the level of IL-6 and other cytokines involved in the cytokine storm cause a change in cell arrangement to further activate the immune response, which after recovery and suppression of the hyperactive immune system, this cell arrangement probably changes to inhibit the immune system, which causes inhibitory markers to increase. The proportion of Treg cells and Th17 cells was affected by SARS-CoV-2 in different ways. Several studies showed severe COVID-19 patients had a significant decrease in Treg cell levels, [45, 57] and increased Th17 cells, [58] subsequence to decrease in the Treg/Th17 cell ratio J o u r n a l P r e -p r o o f IL-6 induces the generation of Th17 cells from naïve T cells and inhibits Treg (iTreg) differentiation [59] . Accordingly, increased serum level of IL-6 contribute to imbalance of the Treg/Th17 ratio [60] . Our result showed with decrease level of IL-6 in discharge patients its ratio of Treg / Th17 increased which facilitates the establishment of immunological tolerance. Additionally, a body of recent data has been illustrated that the reduced frequency and dysfunction of Treg cells in the course of SARS-CoV2 infection lead to disease progression, respiratory system injury, and ARDS [24, 61] . In convinced with these studies, our results depicted that the expression levels of CD4, CD25, and Foxp3 markers relative to Treg cells were reduced in admitted COVID-19 patients while those levels elevated once patients recovered. In conclusion, miRNAs could be considered an early detection of infection in blood streams of COVID-19 patients which dysregulation of miR-200c-3p and miR-421are correlated by the expression of ACE2 and inflammatory cytokine IL-6. Thus, it is speculated that targeting these miRNAs can maintain the level of ACE2 affecting the inflammation/tolerance balance and be promising in the treatment of severe COVID-19 patients. Further studies are needed to elucidate these pathways and warrant our results. The data are presented as mean ± S.D. ** indicate P < 0.01, *** P < 0.001. One-way ANOVA was used to make comparisons between groups. and Foxp3 showed a significant increase at discharge time compared to admission time. The data are presented as mean ± S.D. ** indicate P < 0.01, *** P < 0.001. One-way ANOVA was used to make comparisons between groups. J o u r n a l P r e -p r o o f miRNAs regulate gene expression post-transcriptionally. They generally bind to untranslated region of their target mRNAs and repress protein production by destabilizing the mRNA and translational silencing. Particularly in infected patients, miRNAs have been proposed as promoting biomarkers because they can be readily detected in blood, plasma, serum, and saliva (circulating miRNAs). studies showed that serum miRNAs could serve as a novel prognostic marker for SARS-CoV-2 infection. Meanwhile, ACE2-regulating miRNAs are more important, such as the miR-200 family, especially hsa-miR-200c-3p directly targets ACE2 mRNA leading to decreased ACE2 expression. Furthermore, miR-421-5p can also cause a balance between inflammatory and anti-inflammatory processes and preserve overexpression of HIF-mediated inflammatory genes, leading to inflammation-induced lung damage. Accordingly, assessing the levels of these two miRNAs could be important for coronavirus COVID-19 (SARS-CoV-2) patients. Coronavirus disease ( COVID-19) : situation report Clinical characteristics of coronavirus disease 2019 in China Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges Inflammation triggered by sars-cov-2 and ace2 augment drives multiple organ failure of severe covid-19: Molecular mechanisms and implications SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor COVID-19 and diabetes mellitus: from pathophysiology to clinical management The renin-angiotensin-aldosterone system and its suppression Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia. Cellular signalling miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2 Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421 Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy Application of newly developed SARS-CoV2 serology test along with real-time PCR for early detection in health care workers and on-time plasma donation Cytokines in inflammatory disease IL-6: regulator of Treg/Th17 balance IL-6: relevance for immunopathology of SARS-CoV-2. Cytokine & growth factor reviews Human Seminal Plasma Fosters CD 4+ Regulatory T-cell Phenotype and Transforming Growth Factor-β1 Expression Tregs and rethinking cancer immunotherapy Tregs in immunotherapy: opportunities and challenges Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+ CD4+ regulatory cells that control intestinal inflammation The inhibitory cytokine IL-35 contributes to regulatory T-cell function Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+ CD25+ regulatory T cells is interleukin 10 dependent Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clinical infectious diseases Clinical and immunological features of severe and moderate coronavirus disease 2019 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet FOXP3 and the regulation of Treg/Th17 differentiation. Microbes and infection MicroRNAs and the immune response to respiratory virus infections. Expert review of clinical immunology Respiratory syncytial virus infection of airway cells: role of microRNAs Therapeutic potential of miRNAs targeting SARS-CoV-2 host cell receptor ACE2. Meta gene Upregulated miR-200c may increase the risk of obese individuals to severe COVID-19. medRxiv Circulating miR-421 targeting leucocytic angiotensin converting enzyme 2 is elevated in patients with chronic kidney disease A comprehensive investigation of the mRNA and protein level of ACE2, the putative receptor of SARS-CoV-2, in human tissues and blood cells MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes Hypoxic regulation of angiotensin-converting enzyme 2 and Mas receptor in human CD34+ cells Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63 Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirusinduced lung injury Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive care medicine Attenuation of bleomycin-induced pulmonary fibrosis by intratracheal administration of antisense oligonucleotides against angiotensinogen mRNA. Current pharmaceutical design SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. cell SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). The Journal of pathology miRNA-200c-3p is crucial in acute respiratory distress syndrome. Cell discovery Monocytic angiotensin-converting enzyme 2 relates to atherosclerosis in patients with chronic kidney disease The laboratory tests and host immunity of COVID-19 patients with different severity of illness MiR-200c-3p expression may be associated with worsening of the clinical course of patients with COVID-19 Nasal ACE2 levels and COVID-19 in children High expression of ACE2 in the human lung leads to the release of IL6 by suppressing cellular immunity: IL6 plays a key role in COVID-19 Significant changes of CD4, FOXP3, CD25, and IL6 expression level in Iranian COVID-19 patients. Gastroenterology and hepatology from bed to bench Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients Prognostic bioindicators in severe COVID-19 patients High expression of ACE2 in the human lung leads to the release of IL6 by suppressing cellular immunity: IL6 plays a key role in COVID-19 Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet respiratory medicine The laboratory tests and host immunity of COVID-19 patients with different severity of illness TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan Immunology, and Infection, TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib Reciprocal developmental pathways for the generation of pathogenic effector TH 17 and regulatory T cells The Cytokine Release Syndrome (CRS) of Severe COVID-19 and Interleukin-6 Receptor (IL-6R) Antagonist Tocilizumab man be the Key to Reduce the Mortality Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls The authors declare that the research was performed without any financial relationships that could have appeared to influence the work reported in this paper.